Complete List of Analytical Studies
CompassRx
NPDUIS CompassRx, 2nd edition – 2013/14 (PDF - 4.02 MB)
NPDUIS Compass Rx 1st Edition, March 2015 (PDF - 4,036 Kb)
Analysis Brief: NPDUIS CompassRx, 1st Edition (PDF - 804 Kb)
Generic Drugs
Generics360 – Generic Drugs in Canada, 2014 (PDF - 1.75 MB)
Generic Drugs in Canada, 2013, December 2014 (PDF - 465 Kb)
Analysis Brief: Generic Drugs in Canada, 2013 (PDF)
Analytical Snapshot: International Generic Price Comparison, Early 2011, August 2013 (PDF)
Generic Drugs in Canada: International Price Comparisons and Potential Cost Savings, September 2011 (PDF)
Generic Drugs in Canada: Market Structure – Trends and Impacts, December 2010 (PDF)
Generic Drugs in Canada: Price Trends and International Price Comparisons, 2007, December 2010 (PDF)
Private Drug Plans
Private Drug Plans in Canada - Part 1: Generic Market 2005–2013 (PDF - 3.02 MB)
New Drug Pipeline Monitor
New Drug Pipeline Monitor, 7th Edition – December 2015 (PDF - 1.42 MB)
New Drug Pipeline Monitor, 6th Edition, December 2014 (PDF - 728 Kb)
New Drug Pipeline Monitor, 5th Edition, December 2013
New Drug Pipeline Monitor, 4th Edition, April 2013
New Drug Pipeline Monitor, 3rd Edition, July 2011
New Drug Pipeline Monitor, 2nd Edition, July 2008
New Drug Pipeline Monitor, 1st Edition, June 2007
Other Analytical Reports
Utilization of Prescription Opioids in Canada's Public Drug Plans, 2006/07 to 2012/13, April 2014 (PDF)
The Drivers of Prescription Drug Expenditures – A Methodological Report, December 2013 (PDF)
The Use of Blood Glucose Test Strips in Select Public Drug Plans, 2008, April 2013 (PDF)
Wholesale Up-charge Policies of Canada's Public Drug Plans, December 2011 (Revised January 2012) (PDF)
The Impact of Generic Entry on the Utilization of the Ingredient, September 2011 (Revised May 2012) (PDF)
Public Drug Plan Dispensing Fees: A Cost-Driver Analysis, 2001/02 to 2007/08, September 2011 (PDF)
Baby-Boomer Effect on Prescription Expenditures and Claims, December 2010 (PDF)
Use of the World Health Organization Defined Daily Dose in Canadian Drug Utilization and Cost Analyses, December 2010 (PDF)
Posters
2015 CHSPR Health Policy Conference (Vancouver, B.C.) – March 2015
Generic Drugs in Canada, 2013 (PDF - 373 kb)
Cost Drivers of Private Drug Plans in Canada, 2012/13 (PDF - 400 kb)
Cost Drivers of Public Drug Plans in Canada, 2012/13 ( PDF - 1,021 kb)
The Use of Gabapentin in Public Drug Plans (PDF - 1,480 kb)
Monitoring New Drugs in Canada: A Multifaceted Approach (PDF - 326 kb)
Generic Drugs in Canadian Private Plans, 2005–2013 (PDF - 338 kb)
CAHSPR Conference (Toronto, ON) – May 2014
Private Drug Plans in Canada (PDF)
New Drug Pipeline Monitor (PDF)